I wanted to add some commentary on Glycomimetics (GLYC) as I own shares – all of them under 1 dollar as I said I would buy once prior management was removed. The prior management well, mismanaged the company’s trials -…
Tag: biotech
Audio Webinar: Calithera Biosciences Platform And Our Bullish View
In this audio webinar, Danny Cohen and I explain why we are bullish on Calithera Biosciences (CALA). We go over the technology, current data set, upcoming catalysts, and why we believe a deal with $BMY is near to come. We also…
Immunotherapy Explained Part 3 – In Relation To Affimed
Immunotherapy Explained Part 2 – In Relation To Affimed. In part 3 here we explain and expand in the science of Immunotherapy and explain in part how $AFMD is differentiated, explain the $MRK Keytruda/AFM 13 trial plus a lot more.…
Video Slide Presentation Immunotherapy + Affimed Explained Part 1
Immunotherapy Explained Part 1. Danny and I break down immunotherapy in this 3 part series. In part 1, we discuss an overview of the basic biology behind immunotherapy. Video is around 1 hour long. We talk about the various approaches…
Updated: Immunotherapy-Oncology Webinar – Monday May 23rd @ 1 PM EST.
What is immunotherapy? Danny Cohen and myself will be doing a live webinar on Monday May 23rd at 1 pm EST, 10 am Western time. The webinar will be recorded and uploaded to this site afterwards. Topics explained and included…
Why This Small Cap Biotech Is Likely To Rally Soon
In small cap developmental biotech, we see a lot of creative financing, and when we understand how it works, we can profit from it. These types of biotech charts normally trade in a consistent ‘channel pattern.’ and when we spot…
Free Public Preview Video: Explanation on Current Market Situation Jan.29, 2014
Explanation on Current Market Situation Jan.29, 2014. $SPY reviewed later on in video. Mis-speak, I said “76 Million jobs” I later correct that to the proper “76 thousand jobs” I speak about potential head and shoulders in the charts, as…
BioPharma Catalyst And Investment Pick In Focus Synergy Pharma
Today at stockmatusow, we focus on a Bio-Pharmaceutical company with several near-term catalysts and give our thesis why we believe the company makes for a good long term speculative investment. Synergy Pharmaceuticals (SGYP) focuses on the development of drugs to…
Catalyst Trade Alert *UPDATED With Chart* – Re-Bought Progenics (PGNX) – Price Target Opinion = $6.50
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for…
Video: (Updated) My Solta-Zeltiq Merger Thesis (Public Free Video)
Hi guys, Scott here with ya! Because so many people are asking me about $SLTM and what I believe is going on with them, I have made a public video for you to listen to my thesis regarding this matter.…